Johnson Johnson
World  /  Published 14.10.20

Vaccine: volunteer’s illness halts trials

Johnson & Johnson has paused the large late-stage clinical trial of its coronavirus vaccine because of an “unexplained illness” in one of the volunteers, the company said on Monday. T...
By New York Times News Service in New York

World  /  Published 24.09.20

Vaccine: J&J in last lap

Johnson & Johnson on Wednesday kicked off a final 60,000-person trial of a single-shot Covid-19 vaccine that potentially would simplify distribution of millions of doses compared with leading riva...
By Reuters in Chicago

India  /  Published 09.01.19

Plea for more hip cash

Patients in India who had received faulty hip implants recalled by Johnson & Johnson on Wednesday asked a government panel to raise the proposed compensation taking into account their unique circu...
By Our Special Correspondent in New Delhi

India  /  Published 17.05.20

India cuts Covid test swab price to one-tenth

As Covid-19 pandemic spread quickly, India faced twin challenge—short supply of testing swabs and those imported from China at a steep price of Rs 17 per stick were proving to be inferior.A solution...
By PTI in New Delhi

India  /  Published 29.11.18

Govt has formula for hip implant damages

The Union health ministry on Thursday approved a formula to calculate compensation amounts for patients in India who had received faulty hip implants manufactured by a Johnson & Johnson subsidiary...
By Our Special Correspondent in New Delhi


World  /  Published 27.08.19

J&J urged to pay $572m in opioid trial

A judge in Oklahoma on Monday ruled that Johnson & Johnson had intentionally played down the dangers and oversold the benefits of opioids, and ordered it to pay the state $572 million in the first...
By Jan Hoffman/New York Times News Service in New York

Health  /  Published 15.10.18

Hip implant victims sceptical of fair deal

Patients in India who had received faulty hip implants from Johnson&Johnson subsidiary on Monday complained to the Union health ministry about what they say is lack of transparency and dialogue in...
By Our Special Correspondent in New Delhi

Opinion  /  Published 06.12.18

Corruption in the medical devices industry

Ethics, or just scruples, are no longer part of the dictionary of those working in the medical industry. A recent investigation into the supply of medical devices in India by the International Consort...
By The Editorial Board in

India  /  Published 19.05.19

Hype & fizzle: Factory typifies Modinomics

It was supposed to be Johnson & Johnson’s biggest manufacturing plant in India. It was to eventually employ at least 1,500 people and help bring development to a rural area near Hyderabad.Yet, t...
By Reuters in New Delhi

India  /  Published 08.02.19

Opposition to patent on TB drug bedaquiline

Two persons who survived tuberculosis have filed an opposition to a patent application by a pharmaceutical company on bedaquiline, a medicine prescribed for multi-drug-resistant TB but still not avail...
By G.S. Mudur in New Delhi


Download our latest App

to get update on the go...


Copyright © 2020 The Telegraph. All rights reserved.